Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells

International Journal of Gynecological Cancer

Volumn 24, Issue 5, 2014, Pages 824-828

  De Guadalupe Chávez López, María ^a   Hernández Gallegos, Elizabeth ^a   Vázquez Sánchez, Alma Y ^a   Gariglio, Patricio ^a   Camacho, Javier ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Astemizole; Cervical cancer; Ether go go; Imipramine; Potassium channels

Indexed keywords

ASTEMIZOLE; EAG1 PROTEIN; IMIPRAMINE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; ANTIALLERGIC AGENT; KCNH1 PROTEIN, HUMAN; POTASSIUM CHANNEL HERG; TUMOR MARKER;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; DRUG EFFECTS; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; UTERINE CERVICAL NEOPLASMS; WESTERN BLOTTING;

ANTI-ALLERGIC AGENTS; APOPTOSIS; ASTEMIZOLE; BLOTTING, WESTERN; CELL PROLIFERATION; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84904116387     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000151     Document Type: Article

References (30)

1. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164:1017-1025.
2. World HealthOrganization (WHO). Cervical Cancer Incidence in Mexico. Available at: http://www.who.int/infobase/report.aspx? rid=119. Accessed April 11, 2013.
3. Suzuki K. Current therapeutic strategy for multiple myeloma. Jpn J Clin Oncol. 2013;43:116-124.
4. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;12: 982-10019.
5. Pardo LA, Stuhmer W. Eag1: an emerging oncological target. Cancer Res. 2008;68:1611-1613.
6. Garcia-Quiroz J, Camacho J. Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem. 2011;11:307-314.
7. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006;147:S127-S135.
8. Ishikawa M, Fujita R, Takayanagi M, et al. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole. Biol Pharm Bull. 2000;23:112-115.
9. Bianchi L, Wible B, Arcangeli A, et al. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res. 1998;58:815-822.
10. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440:463-469.
11. Reynolds JL, Akhter J, Morris DL. In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines. Melanoma Res. 1996;6:95-99.
12. Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, et al. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Receptors Channels. 2001;7: 345-356.
13. Pardo LA, del Camino D, Sanchez A, et al. Oncogenic potential of EAG K(+) channels. EMBO J. 1999;18:5540-5547.
14. Occhiodoro T, Bernheim L, Liu JH, et al. Cloning of a human ether-A-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett. 1998;434:177-182.
15. Hemmerlein B, Weseloh RM, Mello de Queiroz F, et al. Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer. 2006;5:41.
16. Farías LM, Ocana DB, Díaz L, et al. Ether à go-go potassium channels as human cervical cancer markers. Cancer Res. 2004;64: 6996-7001.
17. Ousingsawat J, Spitzner M, Puntheeranurak S, et al. Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res. 2007;13:824-831.
18. Meyer R, Schonherr R, Gavrilova-Ruch O, et al. Identification of ether a go-go and calcium-Activated potassium channels in human melanoma cells. J Membr Biol. 1999;171:107-115.
19. Agarwal JR, Griesinger F, StühmerW, et al. The potassiumchannel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer. 2010;9:18.
20. Asher V, Khan R, Warren A, et al. The Eag potassium channel as a new prognostic marker in ovarian cancer. Diagn Pathol. 2010;5:78.
21. Diaz L, Ceja-Ochoa I, Restrepo-Angulo I, et al. Estrogens and human papilloma virus oncogenes regulate human ether-A-go-go-1 potassium channel expression. Cancer Res. 2009;69:3300-3307.
22. Downie BR, Sánchez A, Knotgen H, et al. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem. 2008;283:36234-36240.
23. García-Becerra R, Díaz L, Camacho J, et al. Calcitriol inhibits Ether-A go-go potassiumchannel expression and cell proliferation in human breast cancer cells. Exp Cell Res. 2010;316:433-442.
24. Gómez-Varela D, Zwick-Wallasch E, Knotgen H, et al. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res. 2007;67: 7343-7349.
25. Weber C, Mello de Queiroz F, Downie BR, et al. Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J Biol Chem. 2006; 281:13030-13037.
26. Gavrilova-Ruch O, Schönherr K, Gessner G, et al. Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol. 2002;188:137-149.
27. Ortiz CS, Montante-Montes D, Saqui-Salces M, et al. Eag1 potassium channels as markers of cervical dysplasia. Oncol Rep. 2011;26:1377-1383.
28. Rodríguez-Rasgado JA, Acuna-Macías I, Camacho J. Eag1 channels as potential cancer biomarkers. Sensors (Basel). 2012; 12:5986-5995.
29. Breier A, Gibalova L, Seres M, et al. New insight into p-glycoprotein as a drug target. Anticancer Agents Med Chem. 2013;13:159-170.
30. LinH, Li Z, Chen C, et al. Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether a go-go K+ channel. PLoS One. 2011;6:e20362.